Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of IMPLANON and Radiopaque IMPLANON
NCT00620464Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- May 2005
- Primary completion
- Feb 2009
- Modality
- Orthosteric Ligands
01
Overview
Phase 3, randomised, double-blind trial of etonogestrel in contraception (2 arms), sponsored by Organon & Co. Primary endpoint: Bioequivalence of Implanon® and Radiopaque Implanon at 3 years. Started May 2005; status: completed.
02
Drugs
etonogestrel
03
Conditions
contraception
Beyond the preview
Go deeper on NCT00620464.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00620464.